Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. - Humbert,M.; Beasley,R.; Ayres,J. (Allergy, 2005)